Current and Emerging Medical Therapies for Primary Hyperhidrosis
Dermatology and Therapy, ISSN: 2190-9172, Vol: 7, Issue: 1, Page: 25-36
2017
- 56Citations
- 73Captures
- 1Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations56
- Citation Indexes55
- 55
- CrossRef38
- Patent Family Citations1
- Patent Families1
- Captures73
- Readers73
- 73
- Mentions1
- News Mentions1
- News1
Most Recent News
Community Pharmacy Update on Hyperhidrosis: A Focus on New Treatment Options.(CONTINUING EDUCATION: THIS ACTIVITY IS SUPPORTED BY AN EDUCATIONAL GRANT FROM DERMIRA, INC.)
INTRODUCTION Hyperhidrosis is a condition of excess sweating beyond what is physiologically necessary. (1) It is known to affect patients' quality of life and cause
Review Description
Hyperhidrosis is defined as the production of sweat beyond what is physiologically necessary to maintain thermal homeostasis. This disease state may (and typically does) have a significant impact on the patient’s quality of life. Medications including antiperspirants, anticholinergics, and botulinum toxin have been shown to be effective in the management of hyperhidrosis. Several medical device technologies have also proven to be effective. This review article will explore the current and emerging pharmacological and medical device treatments for hyperhidrosis and provide a framework for treating patients who suffer with primary forms of hyperhidrosis.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85014679580&origin=inward; http://dx.doi.org/10.1007/s13555-016-0148-z; http://www.ncbi.nlm.nih.gov/pubmed/27787745; http://link.springer.com/10.1007/s13555-016-0148-z; https://dx.doi.org/10.1007/s13555-016-0148-z; https://link.springer.com/article/10.1007/s13555-016-0148-z
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know